In late September 2026, the US FDA reported that GE HealthCare initiated a voluntary Class II recall of its Centricity PACS imaging software worldwide after discovering that, under certain conditions, migrated historical imaging data could be linked to the wrong patient, potentially leading to misdiagnosis or delayed care across 1,443 systems. On the same week, GE HealthCare also announced a 14% increase in its quarterly dividend to US$0.04 per share and the upcoming addition of experienced finance leader Pascal Desroches to its board in early 2027, underscoring governance and capital-return decisions as it addresses this software safety issue.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。